Skip to content

Advertisement

  • Poster presentation
  • Open Access

NK cells protect TCR-transgenic mice from developing fetal leukemia

  • 1,
  • 1,
  • 2 and
  • 1
Journal for ImmunoTherapy of Cancer20142 (Suppl 3) :P167

https://doi.org/10.1186/2051-1426-2-S3-P167

  • Published:

Keywords

  • CD25 Expression
  • High CD25
  • Receptor CD28
  • Enlarge Lymph Node
  • Intrinsic Effect

To investigate the intrinsic effect of IL-15 expression on CD8 responses we generated IL-15-deficient OT1 TCR-transgenic mice. These mice died surprisingly at around six months of age exhibiting grossly enlarged lymph nodes, spleens and thymi. The affected organs harbored mainly CD8+ T cells that were low for MHC class I, expressed CD25 and CD24 as well as the co-stimulatory receptors CD28, ICOS and PD1. This phenotype resembled a sub-population of immature CD8 single-positive thymocytes. These co-stimulatory r eceptor-positive CD8 cells (CD8cor) expanded after transfers into mice that lacked NK cells due to IL-15 inhibition or antibody-mediated cell lysis, and NK cells caused in vivo lysis of CD8cor cells. In contrast, the presence of IL-15-dependent CD8+ T cells had no effect on CD8cor cell expansion. In vivo expansions of CD8cor cells also depended on the presence of CD11c-positive dendritic cells while IL-2 activity was dispensable despite high CD25 expression. These data suggest that NK cells prevent the thymic escape of a sub-population of CD8 single-positive thymocytes and their subsequent malignant transformation in TCR-transgenic mice.

Authors’ Affiliations

(1)
Lymphoid Malignancies Branch/CCR/NCI, Bethesda, MD, USA
(2)
Transgenic Mouse Model Laboratory, LASP, NCI, Frederick, MD, USA

Copyright

Advertisement